Group Action Lawyers
Latest News & Updates

Category: Health

pelvic mesh inquiry vaginal mesh implants concerns
May 07, 2019
Legal advice for TVT surgery claims

Following the criticism over the new guidelines that came out last month, we’ve received further enquiries from people asking for advice about TVT surgery claims.

With the issues surrounding vaginal mesh in the news again, here’s some advice for you if you’ve yet to speak to anyone about your options for compensation.

One of the first things we often remind people about is to make sure that you seek advice as soon as you can. There can be a number of timeframes to start a case in a legal action of this nature. Leaving it too late can be the difference between receiving tens of thousands of pounds or getting absolutely nothing as a victim of TVT surgery gone wrong.

Continue Reading…

eye compensation
April 22, 2019
Raindrop near vision inlay recall

The Raindrop Near Vision Inlay recall has been initiated due to an increased risk of corneal haze that patients implanted with the devices may experience.

A Medical Device Alert was issued via the MHRA (Medicines and Healthcare products Regulatory Agency) a few weeks ago. There’s a warning to not implant Raindrop Near Vision Inlays and to dispose of any unused stock of them.

Any patients who have already been implanted with the inlays are to be monitored, and any incidents and problems are to be reported. This recall follows the recent news coverage about the Oculentis recall, which is one of the compensation actions we’re representing people for.

Continue Reading…

hernia mesh compensation claims
March 07, 2019
NHS breast screening problems: Legal Advice!

If you have had NHS breast screening problems, you may be entitled to make a claim for compensation if something has gone horribly wrong.

We’re involved in legal action over the 2018 breast cancer screening scandal where some half a million women didn’t receive their invitation for life-saving checks. The issue arose from a simple IT error that means the letters didn’t go out, and it’s suspected that hundreds of women may have died as a result.

Our lawyers can help you if you have been the victim of NHS breast screening problems like the 2018 scandal. Read more about what we may be able to do for you below.

Continue Reading…

lawyers
February 22, 2019
Yet to start your transvaginal mesh claim? Read this now!

If you’ve yet to start your transvaginal mesh claim for compensation, we recommend that you read this urgent advice about your options for justice.

We know that people put off starting a legal case for many reasons. One of the main ones is the worry about having a formal legal claim. But if you leave it too late, you risk being unable to claim at all.

There can be a number of timeframes involved in a case like this, and we’ve had to turn people away in the past who have missed deadlines to claim. We don’t want you to miss out on your chance for justice. With that in mind, here’s a little useful guidance about making a transvaginal mesh claim for compensation.

Continue Reading…

mom hip implant-concerns
January 18, 2019
Breast cancer screening compensation

If you’ve yet to touch base with us about your No Win, No Fee options for breast cancer screening compensation, please get in touch as soon as you can.

We’re involved in legal action breast cancer screening compensation for the scandal that hit the media last year. This was the IT glitch that cut the age off of letter being sent to the vulnerable group (aged between 68 and 71). The result of the glitch meant some 450,000 women may not have receive their potentially life-saving invitation for breast cancer screening.

Shortly after the news of the scandal hit the press, we were contacted for help. We’ve agreed to act for women affected by the scandal on a No Win, No Fee basis.

Continue Reading…

drug recall
December 07, 2018
Valsartan recall widens

The Valsartan recall widened last month following updated advice from the Medicines and Healthcare Regulatory Authority (MHRA).

Batches of products containing Valsartan that were supplied by Teva UK Ltd and Mylan are being recalled in the UK. This follows on from a drug alert earlier this year that was issued after the discovery that some Valsartan products were contaminated. Legal cases are already underway, and this latest recall involves further batches of the product.

An immediate suspension and quarantine of the additional affected products has been ordered.

Continue Reading…

herbal supplements claim
November 23, 2018
Dangerous vitamin and mineral supplements

Are vitamin and mineral supplements pointless and potentially dangerous? Some experts think they are. What does this mean for users?

An American study claims that some vitamin and mineral supplements don’t provide for any health benefits to the user at all. Worse still, their research also suggested that some may actually increase the risks of death. Some may also be problematic for people with particular conditions, like diabetes.

In an age where health and beauty are important, are being people ripped off? Are some people even being put in danger?

Continue Reading…

cancer screening scandal
November 16, 2018
40,000 patients affected by cervical screening error

Some 40,000 patients are affected by the recent cervical screening error that has led to thousands of letters not being sent out.

Of the 40,000 affected, some 4,000 were in relation to test results that never went out. Up to 200 of those reportedly showed abnormal results where women will have likely needed swift intervention if cancer has been identified.

The number of patients affected is staggering, and this isn’t the first time a simple error has led to a significant blunder of this nature. We’re representing victims of the NHS breast screening scandal where letters for screening didn’t go out due to an IT error.

Continue Reading…

experts warn of buying diet pills online
November 02, 2018
Risperdal compensation deal agreed ahead of trial

A Risperdal compensation deal has been agreed ahead of a trial. This is said to be one of many potentially multi-million-pound settlements over the drug.

Some users who have been taking Risperdal medication have suffered severe side-effects. The use of the drug has also been involved in off-label marketing; i.e. using the drug for alternative reasons than what regulators have approved the drug for.

Off-label marketing can be a real problem for consumers. When pharmaceutical giants see slow sales in particular products, they can be tempted to repackage them and sell them for different uses. Sometimes this isn’t a bad thing, but when the drug isn’t approved for certain uses, and where certain side-effects are prominent in off-label uses, people can suffer.

Continue Reading…

medical alert
July 04, 2018
Roche Diabetes Care test strip errors leads to recall

Roche Diabetes Care test strip errors has led to a recall of a number of home-use and point-of-care glucose monitoring systems.

The Roche Diabetes Care test strip errors are for the following systems: Accu-Chek Aviva; Accu-Chek Performa; and Accu-Chek Inform II.

There is a risk of a strip error message that may lead to either falsely high or falsely low blood glucose results reported.

Continue Reading…

injection warning
June 29, 2018
A troubling testimony in the Gosport War Memorial Hospital deaths

A troubling testimony in the Gosport War Memorial Hospital deaths has been recounted in the recent independent inquiry that deemed some 450 deaths at the hospital were linked to an unsafe opioid-use policy.

Families who have been fighting for an inquiry for years have finally received the news that they say they knew all along: that their loved-ones died in the hospital prematurely.

At the centre of the Gosport War Memorial Hospital deaths scandal is Dr Jane Barton; the GP stationed there who claims that she was only ever doing the best for her patients. One particularly troubling testimony from 2001 that was recounted in the independent report paints a different story entirely.

Continue Reading…

May 30, 2018
J & J and its supplier challenge evidence in talcum powder cancer case

J & J and its supplier are set to still challenge evidence in a talcum powder cancer case where a verdict has already been reached to the tune of $117m in damages in the Claimant’s favour.

Reportedly, pharmaceutical giant J & J and its supplier of the talcum powder that’s at the centre of the cancer cases against them are trying to argue that the Claimant failed to prove that his mesothelioma was caused by the talc product.

The $117m damages award in this monumental legal battle is one of many verdicts that have paved the way for J & J paying millions to victims who claim their cancer was caused by its talcum powder product.

Continue Reading…